Enveric Biosciences Current Valuation vs. Return On Asset
| ENVB Stock | USD 0.33 0.04 10.81% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.22 | 0.23 |
|
|
For Enveric Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Enveric Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Enveric Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Enveric Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Enveric Biosciences over time as well as its relative position and ranking within its peers.
Enveric |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enveric Biosciences. If investors know Enveric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enveric Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.42) | Revenue Per Share 37.678 | Quarterly Revenue Growth (0.07) | Return On Assets (0.81) | Return On Equity (2.06) |
The market value of Enveric Biosciences is measured differently than its book value, which is the value of Enveric that is recorded on the company's balance sheet. Investors also form their own opinion of Enveric Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Enveric Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enveric Biosciences' market value can be influenced by many factors that don't directly affect Enveric Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enveric Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enveric Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enveric Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Enveric Biosciences Return On Asset vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Enveric Biosciences's current stock value. Our valuation model uses many indicators to compare Enveric Biosciences value to that of its competitors to determine the firm's financial worth. Enveric Biosciences is rated # 4 in current valuation category among its peers. It is rated # 5 in return on asset category among its peers . As of December 19, 2024, Return On Assets is expected to decline to -0.0042. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Enveric Biosciences' earnings, one of the primary drivers of an investment's value.Enveric Current Valuation vs. Competition
Enveric Biosciences is rated # 4 in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 114.27 Million. Enveric Biosciences has negative current valuation of (3.44 Million) making no impact on the industry.
Enveric Return On Asset vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enveric Biosciences |
| = | (3.44 M) |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Enveric Biosciences |
| = | -0.8 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Enveric Return On Asset Comparison
Enveric Biosciences is currently under evaluation in return on asset category among its peers.
Enveric Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Enveric Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Enveric Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Enveric Biosciences' change in net profit over the period of time. It can combine multiple indicators of Enveric Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -569.7 K | -598.2 K | |
| Operating Income | -16.4 M | -15.6 M | |
| Net Loss | -17.3 M | -16.4 M | |
| Income Tax Expense | 28.9 K | 30.4 K | |
| Income Before Tax | -17.3 M | -16.4 M | |
| Total Other Income Expense Net | -814.4 K | -773.7 K | |
| Net Interest Income | 3 K | 3.2 K | |
| Net Loss | -22.5 M | -23.7 M | |
| Net Loss | -44.1 M | -41.9 M | |
| Interest Income | 3.3 K | 3 K | |
| Change To Netincome | 41 M | 43.1 M | |
| Net Loss | (0.01) | (0.01) | |
| Income Quality | 0.82 | 0.77 |
Enveric Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Enveric Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Enveric Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Enveric Biosciences' important profitability drivers and their relationship over time.
Use Enveric Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enveric Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will appreciate offsetting losses from the drop in the long position's value.Enveric Biosciences Pair Trading
Enveric Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Enveric Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enveric Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enveric Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enveric Biosciences to buy it.
The correlation of Enveric Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enveric Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enveric Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enveric Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Enveric Biosciences position
In addition to having Enveric Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Health Care ETFs Thematic Idea Now
Health Care ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Health Care ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Care ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
To fully project Enveric Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Enveric Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Enveric Biosciences' income statement, its balance sheet, and the statement of cash flows.